209 related articles for article (PubMed ID: 28893228)
1. XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
Hussain AR; Siraj AK; Ahmed M; Bu R; Pratheeshkumar P; Alrashed AM; Qadri Z; Ajarim D; Al-Dayel F; Beg S; Al-Kuraya KS
BMC Cancer; 2017 Sep; 17(1):640. PubMed ID: 28893228
[TBL] [Abstract][Full Text] [Related]
2. Role of X-Linked Inhibitor of Apoptosis as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Hussain AR; Bu R; Ahmed M; Jehan Z; Beg S; Al-Sobhi S; Al-Dayel F; Siraj AK; Uddin S; Al-Kuraya KS
J Clin Endocrinol Metab; 2015 Jul; 100(7):E974-85. PubMed ID: 25974735
[TBL] [Abstract][Full Text] [Related]
3. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
Prabhu KS; Siveen KS; Kuttikrishnan S; Iskandarani A; Tsakou M; Achkar IW; Therachiyil L; Krishnankutty R; Parray A; Kulinski M; Merhi M; Dermime S; Mohammad RM; Uddin S
PLoS One; 2017; 12(7):e0180895. PubMed ID: 28704451
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.
Hussain AR; Uddin S; Ahmed M; Bu R; Ahmed SO; Abubaker J; Sultana M; Ajarim D; Al-Dayel F; Bavi PP; Al-Kuraya KS
J Pathol; 2010 Oct; 222(2):180-90. PubMed ID: 20632385
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment.
Siraj AK; Pratheeshkumar P; Parvathareddy SK; Divya SP; Al-Dayel F; Tulbah A; Ajarim D; Al-Kuraya KS
Oncotarget; 2018 Dec; 9(99):37319-37332. PubMed ID: 30647872
[TBL] [Abstract][Full Text] [Related]
6. Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
Strekalova E; Malin D; Rajanala H; Cryns VL
Breast Cancer Res Treat; 2017 Jun; 163(3):435-447. PubMed ID: 28324269
[TBL] [Abstract][Full Text] [Related]
7. Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer.
Rajput S; Kumar BN; Sarkar S; Das S; Azab B; Santhekadur PK; Das SK; Emdad L; Sarkar D; Fisher PB; Mandal M
PLoS One; 2013; 8(4):e61342. PubMed ID: 23613836
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
Xie X; Tang B; Zhou J; Gao Q; Zhang P
Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
10. X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.
Qian H; Huang T; Chen Y; Li X; Gong W; Jiang G; Zhang W; Cheng S; Li X; Li P
J Cancer Res Ther; 2018 Sep; 14(Supplement):S648-S655. PubMed ID: 30249882
[TBL] [Abstract][Full Text] [Related]
11. A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma.
Yamada T; Horinaka M; Shinnoh M; Yoshioka T; Miki T; Sakai T
Int J Oncol; 2013 Oct; 43(4):1080-6. PubMed ID: 23900601
[TBL] [Abstract][Full Text] [Related]
12. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
13. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro.
Fu X; Pang X; Qi H; Chen S; Li Y; Tan W
Clin Transl Oncol; 2016 Mar; 18(3):277-82. PubMed ID: 26209051
[TBL] [Abstract][Full Text] [Related]
14. Synergism between NF-kappa B inhibitor, celastrol, and XIAP inhibitor, embelin, in an acute myeloid leukemia cell line, HL-60.
Pazhang Y; Jaliani HZ; Imani M; Dariushnejad H
J Cancer Res Ther; 2016; 12(1):155-60. PubMed ID: 27072230
[TBL] [Abstract][Full Text] [Related]
15. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X
Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405
[TBL] [Abstract][Full Text] [Related]
16. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.
Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR
Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521
[TBL] [Abstract][Full Text] [Related]
17. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.
Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L
Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression.
Aird KM; Ding X; Baras A; Wei J; Morse MA; Clay T; Lyerly HK; Devi GR
Mol Cancer Ther; 2008 Jan; 7(1):38-47. PubMed ID: 18202008
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells.
Wang DG; Sun YB; Ye F; Li W; Kharbuja P; Gao L; Zhang DY; Suo J
Mol Cell Biochem; 2014 Jan; 386(1-2):143-52. PubMed ID: 24136460
[TBL] [Abstract][Full Text] [Related]
20. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.
Aird KM; Ghanayem RB; Peplinski S; Lyerly HK; Devi GR
Mol Cancer Ther; 2010 May; 9(5):1432-42. PubMed ID: 20406946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
